2019 schedule

All day long : 1x1 meetings between international investors, European biotech, medtech, digital Health and pharmaceutical compagnies

- Maryvonne Hiance - Chairman, FRANCE BIOTECH
- Bruno Le Maire - French Minister of Economy and Finance

Moderated by Christian Pierret - Former French Minister of Industry

Speakers :
- Jean-Marc Bourez, Managing Director France - EIT HEALTH
- Antoine De Lachaux, Investment Officer - EUROPEAN INVESTMENT BANK
- Joanna Dupont-Inglis, General Secretary - EUROPABIO
- Ivana Magovčević-Liebisch, Ph.D., J.D - IPSEN
- Thibaut Roulon, Investment Director at Innobio - BPI FRANCE

Moderated by Paul Barrett – Facilitator
- Delphine Le Louet, Equity research senior analyst, Biotech/medtech and European Healthcare - SOCIETE GENERALE
– Marc Le Bozec, Fund Manager Private Equity – FINANCIERE ARBEVEL
– Cédric Moreau, Partner – SOFINNOVA PARTNERS
– Sophie Pierrin Lepinard, Investment manager in Healthcare – BNP PARIBAS DEVELOPPEMENT

Moderated by Eric Forest, Head of listing France – EURONEXT; CEO – Enternext
– Robert Berger, Managing Director, Head of Healthcare Equity Advisory – ROTHSCHILD & CO.
– Alain Decombe, Paris Managing Partner – DECHERT LLP
– Olivier Garnier, Founder & Managing Partner – BRYAN, GARNIER & CO
– Isabella Schidrich, Senior Managing Director – NASDAQ STOCK EXCHANGE
– Lilian Stern, Principal – STERN IR

With a special guest: Sonia Wieder-Atherton, Internationally recognized cellist

Moderated by:
– Claude Bertrand, Executive VP Research and Development – SERVIER
– Wolf Hervé Fridman, Professor of immunology – UNIVERSITY PARIS DESCARTES
– Véronique Blanc, Program Director Immune-Oncology Research – SERVIER
– Fabrice Denis, Oncologist – CENTRE JEAN BERNARD
– Joël Doré, Research Director – INRA
– Alexander Eggermont, Managing Director – GUSTAVE ROUSSY INSTITUTE

– Serge Weinberg, Chairman of the Board of Directors – SANOFI
– Hervé Brailly, Chairman – INNATE PHARMA

Moderated by:
– Eric Falcand, VP Global Head of Business Development & Licensing – SERVIER
– Christian Policard, Senior Partner – BDC LIFESCIENCES
– Nissim Darvish, Senior Managing Director – ORBIMED
– David Lawrence, CFO – VALNEVA
– Jongmoon Kim , CEO – TOOLGEN
– Julie Puype, General Manager – TAKEDA France
– Oded N Spindel, Ph.D., MBA, VP – H.C. Wainwright & Co, USA

Moderated by Francois Nicolas, Chief Digital Officer – GUERBET
– Nozha Boujemaa, Chief Science & Innovation Officer – MEDIAN TECHNOLOGIES
– Achille Lerpinière, Head Project Manager at Health Data Hub, attached to the Ministry of Health
– Françoise Simon, Professor University of Columbia & University of Nantes
– Wim Van Hecke, CEO – ICOMETRIX
– Sebastien Woynar, MD Director, Venture – LBO Ventures

Moderated by Paul Barrett – Facilitator
–Dr. Emilio Erazo-Fischer, MBA, Global BD & Licensing Oncology -BOEHRINGER INGELHEIM

– Patrick Dey, VP, Global Head Digital Health & Innovation – AMGEN
– Jean-Frederic Petit-Nivard, Pharma Development Director – OWKIN

– Sandrine Coulange, Health program Director – AXA Next
– Marc Julien, CEO – DIABELOOP

– Véronique Riethuisen, Sr VP, Global Head of Business Development & Alliance Management – IPSEN

Moderated by Pierre Courteille, Pharmacist & MBA Chicago Booth, CCO & VP BD – ABIVAX; VP – FRANCE BIOTECH
– Gil Beyen, MBA, Chicago Booth; Chairman & CEO – ERYTECH PHARMA SA
– Jeffrey Hubbell, Ph.D., Eugene Bell Professor in Tissue Engineering – UNIVERSITY OF CHICAGO
– Sophie Kornowski, PhD & MBA, Chicago Booth; Senior Partner – GURNET POINT CAPITAL LLC
– Starr Marcello, MBA, Chicago Booth; Deputy Head, Polsky Center for Entrepreneurship and Innovation; Assistant Professor of Entrepreneurship – UNIVERSITY OF CHICAGO
– Melody Swartz, Ph.D., William B. Ogden Professor of Molecular Engineering – UNIVERSITY OF CHICAGO

Moderated by Philippe Pouletty, co-founder & Managing Director- TRUFFLE CAPITAL
– Gabriela Apiou, Ph.D., Director of Strategic Alliances – MASS GENERAL RESEARCH INSTITUTE & Assistant Professor of Dermatology – HARVARD MEDICAL SCHOOL

- Maryvonne Hiance, Chairman - FRANCE BIOTECH